Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

Proactive news headlines: Faron, Genflow, Union Jack Oil and more

Elixir Energy Ltd (ASX:EXR, OTC:ELXPF) has delivered what could be the deepest unstimulated flow of gas in onshore Australia east of the Perth Basin at its 100% owned Grandis project in Queensland, adjacent to the Wallumbilla gas hub.

Elixir reported a highly encouraging initial flow test in the Lorelle Sandstone at the Daydream-2 well, achieving a stabilised flow rate of 1.3 million standard cubic feet per day (MMSCFPD), without stimulation, and peak rate of 2.3 million MMSCFPD.

Read more

When the Grayscale Bitcoin Trust (GBTC) began trading on the OTCQX Market in 2015, it was the first publicly traded Bitcoin fund in the United States.

In collaboration with OTC Markets Group Inc. (OTCQX:OTCM), Grayscale Investments facilitated public trading of their flagship product on OTCQX for nearly eight years, which allowed GBTC to reach a broader investor base and achieve a new level of success without the traditional route of registering with the SEC for public trading on major exchanges like the New York Stock Exchange or Nasdaq.

Read more

Power Nickel Inc (TSX-V:PNPN) announced that it plans to raise C$2 million through a private placement offering of up to 10 million shares at C$0.20 per share.

The company has secured commitments to close the financing, with closing expected to take place next week, Power Nickel CEO Terry Lynch said.

Read more

Nextech3D.AI (CSE:NTAR, OTCQX:NEXCF) announced that it is integrating various AI capabilities from its technology stack into the Toggle platform to enhance 3D modelling productivity.

The company said its AI mesh search algorithm has been installed, allowing 3D modellers to search for quad 3D meshes using a 2D image.

Read more

ARway.ai (CSE:ARWY, OTCQB:ARWYF) announced that it has entered into a paid partner deal with AVR Labs, a United Arab Emirates-based company specializing in extended reality (XR) technologies.

The company, which provides augmented reality (AR) experiences for indoor spaces, said that AVR Labs will be a recognized partner of the company in the Gulf Region and will implement its technology for various customer projects.

Read more

Toronto-listed bitcoin miner and data center operator HIVE Digital Technologies (TSX-V:HIVE, NASDAQ:HIVE) Ltd is hitting the road in April to attend two major industry events in Paris and London.

At Paris Blockchain Week, scheduled for April 9-11, HIVE aims to engage with professionals in the artificial intelligence and Web3 sectors.

Read more

Diversified Energy Company PLC (LSE:DEC, NYSE:DEC) has published its annual sustainability report, for 2023.

This report, the company's fifth, showcases a 33% decrease in methane intensity which, as the company highlighted, surpasses its 2026 target for a 30% reduction and also sees it achieve its 2030 goal of a 50% reduction seven years early.

Read more

Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF), which is focused on longevity and age-related diseases, has successfully raised £715,000 through a combination of placing and subscription for new stock organised by Capital Plus Partners.

Warrants have also been issued along with shares on a one-for-two basis with an exercise price of 2p. Chief executive, Dr Eric Leire, invested £50,000 of his own funds.

Read more

Faron Pharmaceuticals Limited (AIM:FARN) has successfully raised €4.8 million in a share placing as management works on a longer-term funding plan that will allow it to complete a phase II trial of its promising cancer treatment.

Including the €3.2 million convertible loan note, the drug developer has sufficient cash to maintain the required covenant levels and possesses sufficient working capital into June.

Read more

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK